Forum Markets Incorporated (FRMM) Registration Filing summary

Company overview and business model

• Transitioning from a clinical-stage biotechnology company to focus on online blockchain casino operations after acquiring relevant technology and IP in September 2024.

• Plans to establish a blockchain-based iGaming business targeting the global cryptocurrency market, with future expansion into fiat currency wagering and B2B offerings.

• Legacy biotech programs in fibrosis, anti-TNF, and cannabinoid derivatives are being evaluated for monetization or other strategic alternatives.

Financial performance and metrics

• As of June 20, 2025, public float was $4,850,227 based on 3,646,787 shares held by non-affiliates at $1.33 per share.

• Aggregate market value of common equity held by non-affiliates is below $75 million, limiting public primary offerings to one-third of public float in any 12-month period.

Use of proceeds and capital allocation

• Net proceeds from securities sales will be used for working capital, general corporate purposes, and potential acquisitions or investments in complementary businesses.

• Pending use, proceeds will be invested in short-term, interest-bearing, investment-grade securities.